Woodline Partners’s Inozyme Pharma INZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.14M Sell
2025
Q1
$913K Buy
2024
Q4
$2.78M Hold
2024
Q3
$5.25M Buy
2024
Q2
$4.46M Buy
2024
Q1
$6.8M Buy
2023
Q4
$1.28M Buy
2023
Q3
Sell
2023
Q2
$1.61M Buy